CLINIC

Advertisement
Dec 23 2025HEALTH

A Fresh Look at Ivermectin's Role in Mild COVID-19 Treatment

Researchers recently revisited a study on ivermectin's potential in treating mild COVID-19 symptoms. The focus was on a special nasal spray form of the drug. This form is designed to stick to the inside of the nose. The goal was to see if it could help with upper respiratory issues. The study looke

reading time less than a minute
Dec 22 2025HEALTH

How AI is Changing Healthcare at Stanford

Dr. Michael Pfeffer is a busy man. He is the Chief Information Digital Officer at Stanford Health Care and also works as a doctor and teacher. He loves his job because it lets him see how technology can make healthcare better. He thinks technology is most useful when it helps doctors and patients in

reading time less than a minute
Dec 22 2025HEALTH

Do Hospital Alarms Really Stop Falls?

Hospitals often use alarms to alert staff when patients at risk of falling try to move around. But do these alarms actually work? A recent study put them to the test. The study was a randomized clinical trial. This means patients were randomly assigned to either have an alarm or not. The goal was t

reading time less than a minute
Dec 20 2025HEALTH

Decoding the World: The Hurdles and Helpers of Genetic Testing

Genetic testing is becoming a big deal worldwide. It's like having a superpower to peek into someone's DNA. But why isn't everyone using it? There are good reasons and tough challenges. First, let's talk about the good stuff. Genetic testing can spot diseases early. It can help doctors make better

reading time less than a minute
Dec 20 2025BUSINESS

Jyong Biotech: Navigating Market Swings and Future Plans

Jyong Biotech, a biotech company based in Taiwan, has noticed some unusual activity in its stock price and trading volume. This comes just after a lock-up period ended this month. The company is in talks with some investment funds about buying shares, but they say they're not hiding any big news tha

reading time less than a minute
Dec 20 2025FINANCE

Genenta's CEO Invests Big: What It Means for the Company

Genenta Science, a company working on new ways to fight cancer, has some news to share. Their CEO, Pierluigi Paracchi, has been buying up shares of the company. Over time, he's picked up 30, 000 American Depositary Shares, or ADSs, through open-market purchases. No sales have been reported, just buy

reading time less than a minute
Dec 19 2025HEALTH

Young Hearts in Crisis: What's Happening to Adults Under 40 in Cardiac Care?

Cardiac Intensive Care Units (CICUs) are usually thought of as places for older folks. But what about adults under 40? They're a smaller group, but they're not getting the attention they deserve. Researchers wanted to dig deeper into this. They looked at who these young adults are, why they end up

reading time less than a minute
Dec 16 2025HEALTH

A New Hope for Tough-to-Treat Leukemia

In the world of medical research, a new player has emerged that could change the game for people with a tough type of blood cancer called acute myeloid leukemia (AML). This cancer is notorious for being resistant to many treatments, especially in cases with complex genetic issues like MECOM rearrang

reading time less than a minute
Dec 15 2025HEALTH

Can Tech Help Parents Tame Tantrums?

Parents of kids with disruptive behavior disorders often feel lost. They struggle to manage outbursts. But what if technology could lend a hand? Researchers have been exploring this idea. They want to know if digital tools can help. Specifically, tools that give real-time feedback. These tools coul

reading time less than a minute
Dec 15 2025HEALTH

Breaking Barriers: How Denmark is Changing Radiography Research

In Denmark, a shift is happening. Radiography research is moving from classrooms to hospitals. This is big news. It means radiographers can do research right where they work. No need to go back to school for a master's degree. This change is important. It can improve patient care. It can also make

reading time less than a minute